Results 191 to 200 of about 521,694 (302)

Chromatin accessibility shapes development-specific lineage plasticity in hematopoiesis. [PDF]

open access: yesBlood Adv
Palo S   +7 more
europepmc   +1 more source

From Prediction to Decision Making: PBPK and QSP as Regulatory‐Grade NAMs

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1195-1207, November 2026.
New approach methodologies (NAMs) encompass a diverse and rapidly evolving set of experimental and computational tools designed to generate human‐relevant mechanistic data for use in drug development and regulatory decision making. Experimental NAMs provide insights into drug disposition, pharmacological activity, and disease biology that are difficult
Karen Rowland Yeo, Piet H. van der Graaf
wiley   +1 more source

Supplementing With the Vitamin A Metabolite Retinoic Acid Can Alleviate Negative Affective States Caused by SPI1‐Induced Immune and Metabolic Dysfunctions Following Intestinal Barrier Impairment

open access: yesFood Frontiers, Volume 7, Issue 6, November 2026.
ABSTRACT Ulcerative colitis (UC) and depression (DP) are significant comorbidities in epidemiological research. However, the mechanisms underlying UC‐induced DP remain poorly understood. Myeloid differentiation and retinoic acid metabolic dysregulation are implicated in both conditions, yet their interconnection in the context of comorbidity is unclear.
Yang Feng   +7 more
wiley   +1 more source

Case Report: T-Lymphoblastic Leukemia in a Dog With Erythrophagia. [PDF]

open access: yesVet Clin Pathol
Lang FB   +7 more
europepmc   +1 more source

Modulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia

open access: yesHemaSphere, Volume 10, Issue 11, November 2026.
Abstract DNA hypomethylating agents (HMAs) such as 5‐azacytidine (5‐AZA) are a cornerstone in the treatment of acute myeloid leukemia (AML), but development of resistance represents a major clinical challenge. Apart from epigenetic reprogramming of malignant cell clones, therapy with HMA is increasingly recognized to facilitate antineoplastic immunity,
Nadia El Khawanky   +20 more
wiley   +1 more source

Leukemia Cutis at the Diagnosis of Chronic Lymphocytic Leukemia: A Case Report. [PDF]

open access: yesCureus
Mouaine I   +4 more
europepmc   +1 more source

Late acquisition of BCR::ABL1 during clonal evolution of SAMD9-associated MDS with phenotypic shift from AML to B-ALL. [PDF]

open access: yesInt J Hematol
Nakata Y   +15 more
europepmc   +1 more source

Myeloid sarcoma presenting as an isolated pancreatic mass in a 3‐year‐old child

open access: yesJPGN Reports, Volume 7, Issue 4, Page 501-504, November 2026.
Abstract Myeloid sarcoma (MS) is an extramedullary tumor of myeloid precursor cells, frequently associated with acute myeloid leukemia (AML), and rarely occurring in isolation. We present a child with obstructive jaundice secondary to a pancreatic head mass.
Jappmann Kaur Monga   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy